Alphamab Oncology マネジメント
マネジメント 基準チェック /24
Alphamab Oncology's CEO is Ting Xu, appointed in Nov 2008, has a tenure of 6.67 years. total yearly compensation is CN¥6.88M, comprised of 95.2% salary and 4.8% bonuses, including company stock and options. directly owns 33.06% of the company’s shares, worth HK$1.23B. The average tenure of the management team and the board of directors is 5.8 years and 5 years respectively.
主要情報
Ting Xu
最高経営責任者
CN¥6.9m
報酬総額
| CEO給与比率 | 95.2% |
| CEO在任期間 | 16yrs |
| CEOの所有権 | 33.1% |
| 経営陣の平均在職期間 | 5.8yrs |
| 取締役会の平均在任期間 | 5yrs |
経営陣の近況
Recent updates
CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥216m |
| Mar 31 2024 | n/a | n/a | -CN¥213m |
| Dec 31 2023 | CN¥7m | CN¥7m | -CN¥211m |
| Sep 30 2023 | n/a | n/a | -CN¥214m |
| Jun 30 2023 | n/a | n/a | -CN¥218m |
| Mar 31 2023 | n/a | n/a | -CN¥272m |
| Dec 31 2022 | CN¥7m | CN¥6m | -CN¥326m |
| Sep 30 2022 | n/a | n/a | -CN¥309m |
| Jun 30 2022 | n/a | n/a | -CN¥292m |
| Mar 31 2022 | n/a | n/a | -CN¥352m |
| Dec 31 2021 | CN¥7m | CN¥5m | -CN¥412m |
| Sep 30 2021 | n/a | n/a | -CN¥502m |
| Jun 30 2021 | n/a | n/a | -CN¥592m |
| Mar 31 2021 | n/a | n/a | -CN¥510m |
| Dec 31 2020 | CN¥5m | CN¥4m | -CN¥428m |
| Sep 30 2020 | n/a | n/a | -CN¥652m |
| Jun 30 2020 | n/a | n/a | -CN¥877m |
| Mar 31 2020 | n/a | n/a | -CN¥851m |
| Dec 31 2019 | CN¥5m | CN¥3m | -CN¥833m |
報酬と市場: Ting's total compensation ($USD969.67K) is above average for companies of similar size in the Hong Kong market ($USD399.57K).
報酬と収益: Ting's compensation has increased whilst the company is unprofitable.
CEO（最高経営責任者
Ting Xu (51 yo)
16yrs
在職期間
CN¥6,877,000
報酬
Dr. Ting Xu, Ph D., serves Chief Executive Officer at Alphamab Oncology since October 1, 2018. He Founded Alphamab Oncology in November 2008.Dr. Xu serves as Executive Director at Alphamab Oncology since...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder | 16yrs | CN¥6.88m | 33.06% HK$ 1.2b | |
| VP of Corporate Operations & Executive Director | 6.1yrs | CN¥2.97m | データなし | |
| Vice President of Government Affairs & Public Relations | 5.8yrs | データなし | データなし | |
| Senior Vice President of Business Development | 6.5yrs | データなし | データなし | |
| Chief Commercial Officer | 3yrs | データなし | データなし | |
| Joint Company Secretary | 4.3yrs | データなし | データなし | |
| Joint Company Secretary | less than a year | データなし | データなし |
5.8yrs
平均在職期間
51.5yo
平均年齢
経験豊富な経営陣: 9966's management team is seasoned and experienced (5.8 years average tenure).
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder | 6.7yrs | CN¥6.88m | 33.06% HK$ 1.2b | |
| VP of Corporate Operations & Executive Director | 6.1yrs | CN¥2.97m | データなし | |
| Independent Non-Executive Director | 5yrs | CN¥396.00k | データなし | |
| Non-Executive Director | less than a year | データなし | 0.11% HK$ 4.0m | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Independent Non-Executive Director | 5yrs | CN¥396.00k | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Chairman of Scientific Advisory Board | no data | データなし | データなし | |
| Independent Non-Executive Director | 3.3yrs | CN¥378.00k | データなし |
5.0yrs
平均在職期間
55yo
平均年齢
経験豊富なボード: 9966's board of directors are considered experienced (5 years average tenure).